Title: Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2.
Journal: Journal of medicinal chemistry 20180614
Title: Dysregulation of MAP Kinase Signaling Pathways Including p38MAPK, SAPK/JNK, and ERK1/2 in Cultured Rat Cerebellar Astrocytes Exposed to Diphenylarsinic Acid.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20170401
Title: Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2.
Journal: Journal of medicinal chemistry 20150611
Title: Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
Journal: Cancer discovery 20130701
